FAIRFAX, Va.--(BUSINESS WIRE)-- ECS, an IT systems integrator focused on data and AI, cybersecurity, and enterprise transformation solutions, and an ASGN (NYSE: ASGN) brand, has been named the prime contractor on a four-year, $96M contract from the Department of Health and Human Services (HHS) Advanced Research Projects Agency for Health (ARPA-H). The win follows ECS being named a prime contractor on the five-year, $500M indefinite delivery/indefinite quality (IDIQ) Strategic Technical ARPA-H Talent Support (STATS) contract vehicle earlier in 2024.

ECS will work with the ARPA-H mission offices of Health Science Futures (HSF) and Scalable Solutions (SSO) to provide programmatic support services, including thought leadership in the areas of biotechnology, neuroscience, regenerative medicine, and cell therapies. The company will help the HSF and SSO mission offices address scalability challenges across healthcare access and equity, as well as the global supply chain. ECS will also provide strategic planning and advisory support services, including program and financial management, to assist these mission offices in shaping the programs of the future.

"ECS is proud to support ARPA-H in forging the future of science, healthcare, and better health outcomes for our nation's citizens. We are excited to provide foundational support to HSF and SSO, help drive healthcare system innovation, and act as a health transformation agent," said John Heneghan, president of ECS.

Established in 2022, ARPA-H supports the development of high-impact research to drive biomedical and health breakthroughs and deliver transformative, sustainable, and equitable health solutions for all Americans.

The ARPA-H HSF office removes scientific and technological limitations that hinder progress in healthcare, accelerates advances across research areas, and supports cutting-edge research programs that have the potential for real-world change. The ARPA-H SSO office develops innovative solutions that can be widely accessible and affordable, addressing healthcare challenges related to geography, distribution, manufacturing, data, and economies of scale, to ultimately improve health outcomes for all Americans.

"ARPA-H is making history—and its leaders and staff are contributing to work that will help so many people across the nation and all over the world," said Asad Akhtar, vice president of ECS' Federal Health practice. "ARPA-H's HSF and SSO mission offices are performing crucial, groundbreaking research and making strides across numerous areas of biomedicine and health. We are honored to play a part in this mission and this moment."

About ECS

ECS, a key segment of ASGN Incorporated, is a trusted IT systems integrator serving government agencies. ECS provides modern digital solutions that enable fast and efficient decision making and support the effective execution of government agency operations.

ECS' leading-edge AI, cybersecurity, and open data management solutions boost collaboration, innovation, and worker productivity, improve employee and customer experiences, and protect critical agency data and assets. For more information, visit ECStech.com.

About ASGN Incorporated

ASGN Incorporated (NYSE: ASGN) is a leading provider of IT services and solutions across the commercial and government sectors. ASGN helps corporate enterprises and government organizations develop, implement, and operate critical IT and business solutions through its integrated offerings. For more information, please visit asgn.com.

Safe Harbor

Certain statements made in this news release are "forward-looking statements" within the meaning of Section 27A of the Securities Exchange Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and involve a high degree of risk and uncertainty. Forward-looking statements include statements regarding our anticipated financial and operating performance. All statements in this news release, other than those setting forth strictly historical information, are forward-looking statements. Forward-looking statements are not guarantees of future performance and actual results might differ materially. For a full list of risks and discussion of forward-looking statements, please see our Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on February 23, 2024. We specifically disclaim any intention or duty to update any forward-looking statements contained in this news release.